Efficacy of high-dose alkylating agents in patients with estrogen receptor–negative p53-mutated tumors.
Abbreviations: ddEC, dose-dense epirubicin and cyclophosphamide; E, single-agent epirubicin; FAC, 5-fluorouracil, doxorubicin, and cyclophosphamide; pCR, pathologic complete response.